A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

Over 350 million people around the world use dating apps, that’s more people than the entire population of the United States. The rise of dating apps has transformed how people meet, communicate, and ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source plasma is verified as safe, aimed at accelerating production of critical ...

Nigeria has taken delivery of the first batch of 11,520 doses of Lenacapavir injection, a new twice-yearly injectable drug ...

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only ...

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

Scientists at Gladstone Institutes, in collaboration with a team at the San Francisco Veterans Affairs Medical Center, have developed a novel tool—named HIV-seq—for profiling the features of rare ...

What you need to know: The 2019 guidelines from the World Health Organisation require diagnostic tests to be conducted by trained and supervised personnel to ensure accurate results. Last month, the ...